|
1
|
Maluccio M and Covey A: Recent progress in
understanding, diagnosing, and treating hepatocellular carcinoma.
CA Cancer J Clin. 62:394–399. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhong JH, Ke Y, Gong WF, Xiang BD, Ma L,
Ye XP, Peng T, Xie GS and Li LQ: Hepatic resection associated with
good survival for selected patients with intermediate and
advanced-stage hepatocellular carcinoma. Ann Surg. 260:329–340.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Torzilli G, Belghiti J, Kokudo N, Takayama
T, Capussotti L, Nuzzo G, Vauthey JN, Choti MA, De Santibanes E,
Donadon M, et al: A snapshot of the effective indications and
results of surgery for hepatocellular carcinoma in tertiary
referral centers: Is it adherent to the EASL/AASLD
recommendations?: An observational study of the HCC East-West study
group. Ann Surg. 257:929–937. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hsu CY, Liu PH, Hsia CY, Lee YH, Nagaria
TS, Lee RC, Lin HC and Huo TI: Surgical resection is better than
transarterial chemoembolization for patients with hepatocellular
carcinoma beyond the milan criteria: A prognostic nomogram study.
Ann Surg Oncol. 23:994–1002. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
European Association For The Study Of The
Liver, ; European Organisation For Research And Treatment Of
Cancer, . EASL-EORTC clinical practice guidelines: Management of
hepatocellular carcinoma. J Hepatol. 56:908–943. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bruix J and Sherman M; American
Association for the Study of Liver Diseases, : Management of
hepatocellular carcinoma: An update. Hepatology. 53:1020–1022.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kudo M, Izumi N, Kokudo N, Matsui O,
Sakamoto M, Nakashima O, Kojiro M and Makuuchi M; HCC Expert Panel
of Japan Society of Hepatology, : Management of hepatocellular
carcinoma in Japan: Consensus-based clinical practice guidelines
proposed by the Japan society of hepatology (JSH) 2010 updated
version. Dig Dis. 29:339–364. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Feo F and Pascale RM: Multifocal
hepatocellular carcinoma: Intrahepatic metastasis or multicentric
carcinogenesis? Ann Transl Med. 3(4)2015.PubMed/NCBI
|
|
10
|
Yasui M, Harada A, Nonami T, Takeuchi Y,
Taniguchi K, Nakao A and Takagi H: Potentially multicentric
hepatocellular carcinoma: Clinicopathologic characteristics and
postoperative prognosis. World J Surg. 21:860–865. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shimada M, Hamatsu T, Yamashita Y,
Rikimaru T, Taguchi K, Utsunomiya T, Shirabe K and Sugimachi K:
Characteristics of multicentric hepatocellular carcinomas:
Comparison with intrahepatic metastasis. World J Surg. 25:991–995.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang J, Li Q, Sun Y, Zheng H, Cui Y, Li H,
Zhou H and Hao X: Clinicopathologic features between multicentric
occurence and intrahepatic metastasis of multiple hepatocellular
carcinomas related to HBV. Surg Oncol. 18:25–30. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li SL, Su M, Peng T, Xiao KY, Shang LM, Xu
BH, Su ZX, Ye XP, Peng N, Qin QL, et al: Clinicopathologic
characteristics and prognoses for multicentric occurrence and
intrahepatic metastasis in synchronous multinodular hepatocellular
carcinoma patients. Asian Pac J Cancer Prev. 14:217–223. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun JJ, Wang K, Zhang CZ, Guo WX, Shi J,
Cong WM, Wu MC, Lau WY and Cheng SQ: Postoperative adjuvant
transcatheter arterial chemoembolization after R0 hepatectomy
improves outcomes of patients who have hepatocellular carcinoma
with microvascular invasion. Ann Surg Oncol. 23:1344–1351. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dong ZR, Zhang PF, Wang CH, Zhang C, Cai
JB, Shi GM, Ke AW, Sun HC, Qiu SJ, Zhou J and Fan J: Postoperative
adjuvant transcatheter arterial chemoembolization for resectable
multiple hepatocellular carcinoma beyond the Milan criteria: A
retrospective analysis. Am J Cancer Res. 5:450–457. 2014.PubMed/NCBI
|
|
16
|
Liu C, Sun L, Xu J and Zhao Y: Clinical
efficacy of postoperative adjuvant transcatheter arterial
chemoembolization on hepatocellular carcinoma. World J Surg Oncol.
14:1002016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Takenaka K, Adachi E, Nishizaki T,
Hiroshige K, Ikeda T, Tsuneyoshi M and Sugimachi K: Possible
multicentric occurrence of hepatocellular carcinoma: A
clinicopathological study. Hepatology. 19:889–894. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liver Cancer Study Group of Japan, .
Primary liver cancer in Japan. Clinicopathologic features and
results of surgical treatment. Ann Surg. 211:277–287.
1990.PubMed/NCBI
|
|
19
|
Matsumoto Y, Fujii H, Matsuda M and Kono
H: Multicentric occurrence of hepatocellular carcinoma: Diagnosis
and clinical significance. J Hepatobiliary Pancreat Surg.
8:435–440. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rahbari NN, Garden OJ, Padbury R,
Brooke-Smith M, Crawford M, Adam R, Koch M, Makuuchi M, Dematteo
RP, Christophi C, et al: Posthepatectomy liver failure: A
definition and grading by the International Study Group of Liver
Surgery (ISGLS). Surgery. 149:713–724. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Oikawa T, Ojima H, Yamasaki S, Takayama T,
Hirohashi S and Sakamoto M: Multistep and multicentric development
of hepatocellular carcinoma: Histological analysis of 980 resected
nodules. J Hepatol. 42:225–229. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ng IO, Guan XY, Poon RT, Fan ST and Lee
JM: Determination of the molecular relationship between multiple
tumour nodules in hepatocellular carcinoma differentiates
multicentric origin from intrahepatic metastasis. J Pathol.
199:345–353. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chan AC, Chan SC, Chok KS, Cheung TT, Chiu
DW, Poon RT, Fan ST and Lo CM: Treatment strategy for recurrent
hepatocellular carcinoma: Salvage transplantation, repeated
resection, or radiofrequency ablation? Liver Transpl. 19:411–419.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gluer AM, Cocco N, Laurence JM, Johnston
ES, Hollands MJ, Pleass HC, Richardson AJ and Lam VW: Systematic
review of actual 10-year survival following resection for
hepatocellular carcinoma. HPB (Oxford). 14:285–290. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hasegawa K, Kokudo N, Makuuchi M, Izumi N,
Ichida T, Kudo M, Ku Y, Sakamoto M, Nakashima O, Matsui O and
Matsuyama Y: Comparison of resection and ablation for
hepatocellular carcinoma: A cohort study based on a Japanese
nationwide survey. J Hepatol. 58:724–729. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bolondi L, Burroughs A, Dufour JF, Galle
PR, Mazzaferro V, Piscaglia F, Raoul JL and Sangro B: Heterogeneity
of patients with intermediate (BCLC B) Hepatocellular Carcinoma:
Proposal for a subclassification to facilitate treatment decisions.
Semin Liver Dis. 32:348–359. 2012.PubMed/NCBI
|
|
27
|
Xue R, Li R, Guo H, Guo L, Su Z, Ni X, Qi
L, Zhang T, Li Q, Zhang Z, et al: Variable intra-tumor genomic
heterogeneity of multiple lesions in patients with hepatocellular
carcinoma. Gastroenterology. 150:998–1008. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Miao R, Luo H, Zhou H, Li G, Bu D, Yang X,
Zhao X, Zhang H, Liu S, Zhong Y, et al: Identification of
prognostic biomarkers in hepatitis B virus-related hepatocellular
carcinoma and stratification by integrative multi-omics analysis. J
Hepatol. 61:840–849. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kumada T, Nakano S, Takeda I, Sugiyama K,
Osada T, Kiriyama S, Sone Y, Toyoda H, Shimada S, Takahashi M and
Sassa T: Patterns of recurrence after initial treatment in patients
with small hepatocellular carcinoma. Hepatology. 25:87–92. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yamamoto T, Kajino K, Kudo M, Sasaki Y,
Arakawa Y and Hino O: Determination of the clonal origin of
multiple human hepatocellular carcinomas by cloning and polymerase
chain reaction of the integrated hepatitis B virus DNA. Hepatology.
29:1446–1452. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Morimoto O, Nagano H, Sakon M, Fujiwara Y,
Yamada T, Nakagawa H, Miyamoto A, Kondo M, Arai I, Yamamoto T, et
al: Diagnosis of intrahepatic metastasis and multicentric
carcinogenesis by microsatellite loss of heterozygosity in patients
with multiple and recurrent hepatocellular carcinomas. J Hepatol.
39:215–221. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim PT, Jang JH, Atenafu EG, Fischer S,
Greig PD, McGilvray ID, Wei AC, Gallinger S and Cleary SP: Outcomes
after hepatic resection and subsequent multimodal treatment of
recurrence for multifocal hepatocellular carcinoma. Br J Surg.
100:1516–1522. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Taura K, Ikai I, Hatano E, Fujii H, Uyama
N and Shimahara Y: Implication of frequent local ablation therapy
for intrahepatic recurrence in prolonged survival of patients with
hepatocellular carcinoma undergoing hepatic resection: An analysis
of 610 patients over 16 years old. Ann Surg. 244:265–273. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Poon RT, Fan ST, Lo CM, Ng IO, Liu CL, Lam
CM and Wong J: Improving survival results after resection of
hepatocellular carcinoma: A prospective study of 377 patients over
10 years. Ann Surg. 234:63–70. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Llovet JM and Bruix J: Systematic review
of randomized trials for unresectable hepatocellular carcinoma:
Chemoembolization improves survival. Hepatology. 37:429–442. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Llovet JM, Real MI, Montana X, Planas R,
Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Solà R, et al:
Arterial embolisation or chemoembolisation versus symptomatic
treatment in patients with unresectable hepatocellular carcinoma: A
randomised controlled trial. Lancet. 359:1734–1739. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lo CM, Ngan H, Tso WK, Liu CL, Lam CM,
Poon RT, Fan ST and Wong J: Randomized controlled trial of
transarterial lipiodol chemoembolization for unresectable
hepatocellular carcinoma. Hepatology. 35:1164–1171. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cheng X, Sun P, Hu QG, Song ZF, Xiong J
and Zheng QC: Transarterial (chemo)embolization for curative
resection of hepatocellular carcinoma: A systematic review and
meta-analyses. J Cancer Res Clin Oncol. 140:1159–1170. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yin L, Li H, Li AJ, Lau WY, Pan ZY, Lai
EC, Wu MC and Zhou WP: Partial hepatectomy vs. transcatheter
arterial chemoembolization for resectable multiple hepatocellular
carcinoma beyond Milan Criteria: A RCT. J Hepatol. 61:82–88. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nojiri K, Tanaka K, Takeda K, Ueda M,
Matsuyama R, Taniguchi K, Kumamoto T, Mori R and Endo I: The
efficacy of liver resection for multinodular hepatocellular
carcinoma. Anticancer Res. 34:2421–2426. 2014.PubMed/NCBI
|
